跳至主要内容
临床试验/EUCTR2013-000975-33-IS
EUCTR2013-000975-33-IS进行中(未招募)1 期

ovel Assays for the Determination of Urinary 2,8-Dihydroxyadenine and Other Key Urinary Purine Metabolites - Rare Diseases Clinical Research NetworkProtocol Version 1

andspitali - The National University Hospital of Iceland0 个研究点开始时间: 2013年10月3日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Participants will be eligible for inclusion if they meet the following criteria:
  • 1.Are patients 18 year and older who are enrolled in the APRT Deficiency Registry of The Rare Kidney Stone Consortium.
  • 2.Control subjects who are either i) heterozygotes for an APRT mutation or ii) healthy individuals without mutation in the APRT gene.
  • 3.Consent to participation in the study.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 10
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 3

排除标准

  • 1.Patients do not want to interrupt drug treatment as requested.
  • 2.No other exclusion criteria if inclusion criteria are met.

研究者

发起方
andspitali - The National University Hospital of Iceland

相似试验